Henan Lingrui Pharmaceutical Co., Ltd.

¥23.87As of Sun 8 Nov 2026, 12:00 UTC
SSE:600285Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 9.88%
Div yield 4.61%
ROE 24.55%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.04)
PE TTM 16.36
TSR TTM 10.79%
Mkt cap ¥13.54B
ROIC 31.87%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥23
(3.89%)
(92.55%)
Hold 9|3|12|6|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.32
0.34
0.33
0.36
18.69%
25.70%
17.19%
16.09%
Revenue¥B
1.051
1.073
1.071
1.049
5.45%
6.56%
1.52%
(1.18%)
Peers (US$2.029B)
Cap (US$)
PE
2.081B
24.09x
2.037B
13.23x
Capital
TTM
5Y
10Y
Leveragex
0.971
0.798
0.725
EBIT/Intx
0.763
2.257
2.566
Own earn%
(81.29)
(88.15)
(86.77)
Sh yield%
21.97
2.00
3.92
Owners
Insiders/Inst%
7.43
40.54
Short interest%
4.99
SBC / revenue%
0.42
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
0–6
$1 testx
—
Incr. ROIC%
0